荷兰,Harbour Antibodies,
成立于2006年，作为公司的商业化转基因小鼠在荷兰鹿特丹 Erasmus医学中心，荷兰最大的医疗中心正在开发的人类抗体的平台。

Harbour Antibodies BV was founded in 2006 as a company to commercialise transgenic mouse human antibody platforms being developed at the Erasmus MC in Rotterdam, the largest medical center in the Netherlands. Harbour licenses broadly across the pharma/biotech industry, and provides academic collaborators access to the transgenic mouse antibody platforms under MTA. In addition to the derivation of human H2L2 antibodies, transgenic mouse platforms have been developed for the derivation of novel human heavy chain only antibodies (HCAbs), soluble human VH domains and VH domain antibody complexes for use both as research tools and to meet unmet clinical need. The proprietary transgenic mouse platforms are protected by filed and granted patent applications in the major and the expanding healthcare markets.